Martin J Coffey

US Patent:

6524435, Feb 25, 2003

Filed:

May 8, 2000

Appl. No.:

09/566874

Inventors:

Sameer B. Agarwal - Glendale Heights IL
Phillip W. Carter - Naperville IL
Martin J. Coffey - Wheaton IL

Assignee:

Ondeo Nalco Company - Naperville IL

International Classification:

C08L 7301

US Classification:

162 1, 1062032, 162 5, 162 55, 162 77

Abstract:

A method of dispersing hydrophobic particles in aqueous suspensions comprising adding to the suspension an effective amount of an ethylene oxide-propylene oxide block copolymer, wherein the copolymer has a molecular weight of from about 1,000 to about 50,000 and a HLB of from about 1 to about 4 and compositions comprising the ethylene oxide-propylene oxide block copolymer.

US Patent:

6548558, Apr 15, 2003

Filed:

May 17, 2001

Appl. No.:

09/812255

Inventors:

Steven J. Severtson - Shoreview MN
Martin J. Coffey - Wheaton IL

Assignee:

Ondeo Nalco Company - Naperville IL

International Classification:

B01F 1700

US Classification:

516 39, 162 4, 162DIG 4, 510207, 510424, 516 41, 516 42, 516 51

Abstract:

Methods for controlling wax and other contaminants by improving the dispersion of these materials through the addition of contaminant dispersants to the process of recycling paper and paperboard are disclosed. A preferred contaminant dispersant comprises: a) water; b) a plasticizer; c) an anionic dispersant; d) a surfactant wetting agent; and e) either 1) an acid or lecithin and optionally, a base, or 2) a preneutralized component.

US Patent:

6709551, Mar 23, 2004

Filed:

Dec 17, 2001

Appl. No.:

10/023370

Inventors:

Martin J. Coffey - Portage MI
Steven T. Govoni - Joliet IL
Arthur J. Begala - Naperville IL
Ross T. Gray - Plainfield IL
Patrick G. Murray - Yorkville IL

Assignee:

Ondeo Nalco Company - Nsperville IL

International Classification:

D21H 2110

US Classification:

1621681, 1621682, 1621683, 524140, 524141, 524145, 524386, 524460, 526258

Abstract:

This invention is directed to high molecular weight water-soluble polymers comprised of zwitterionic, nonionic and cationic or anionic monomer units, and to the use of these polymers in papermaking processes.

US Patent:

8490782, Jul 23, 2013

Filed:

Oct 23, 2007

Appl. No.:

11/876862

Inventors:

Fang Zhao - Rochester NY, US
Vicki L. Barniak - Fairport NY, US
Martin J. Coffey - Pittsford NY, US
Robert M. Braun - Penfield NY, US

Assignee:

Bausch & Lomb Incorporated - Rochester NY

International Classification:

A45C 11/04

US Classification:

206 51, 2065244

Abstract:

A packaging system for the storage of an ionic, hydrogel contact lens employs an aqueous packaging solution including a phosphorylcholine polymer. Preferably, the solution has an osmolality of at least about 200 mOsm/kg, a pH of about 6 to about 8 and is heat sterilized.

US Patent:

20030143271, Jul 31, 2003

Filed:

Jan 7, 2003

Appl. No.:

10/337583

Inventors:

Gary Ewing - Kalamazoo MI, US
Michael Hawley - Kalamazoo MI, US
Martin Coffey - Portage MI, US
Jeffrey Price - Middlebury IN, US
Stephen MacMillan - Newton PA, US

International Classification:

A61K009/48
A61K009/22

US Classification:

424/468000, 424/452000, 514/161000

Abstract:

A pharmaceutical composition comprises one or more discrete orally deliverable dosage forms, each comprising a poorly soluble coxib component in an amount effective when administered once daily for treatment or prevention of a COX-2 mediated disorder, an aspirin component in a cardioprotective effective amount when administered once daily, and at least one pharmaceutically acceptable excipient; the dosage forms having no substantial barrier to intimate commingling of the coxib and aspirin components. A method of simultaneously treating or preventing a COX-2 mediated disorder and providing cardioprotection comprises orally administering such a pharmaceutical composition to a subject in need thereof.

US Patent:

20030152624, Aug 14, 2003

Filed:

Dec 19, 2002

Appl. No.:

10/325298

Inventors:

Dale Aldrich - Richland MI, US
Randy Wald - Portage MI, US
Anthony Hlinak - Lindenhurst IL, US
Rebanta Bandyopadhyay - Portage MI, US
Martin Coffey - Portage MI, US
Diane Goll - Portage MI, US
Ahmad Mazhary - Algonquin IL, US
Richard Meury - Kalamazoo MI, US
Brian Rohrs - Scotts MI, US
John Skoug - Portage MI, US
Stephen Secreast - Portage MI, US
Dennis Stelzer - Otsego MI, US
Jackie White - Portage MI, US

International Classification:

A61K031/137
A61K009/22

US Classification:

424/468000, 514/649000

Abstract:

Controlled release pharmaceutical compositions comprising tolterodine and a polymer-based release-controlling component and processes for preparing such compositions are provided. The compositions are useful in the treatment of overactive bladder and similar conditions.

US Patent:

20090118262, May 7, 2009

Filed:

Oct 17, 2008

Appl. No.:

12/253341

Inventors:

Brian R. Rohrs - Fairport NY, US
Martin J. Coffey - Pittsford NY, US

International Classification:

A61K 31/55
A61K 31/47
A61P 27/02

US Classification:

51421707, 514311

Abstract:

A pharmaceutical composition includes at least one pharmaceutical component having a low aqueous solubility and at least one non-aqueous water-miscible material. Such a pharmaceutical composition is useful in providing a therapeutically meaningful amount of such pharmaceutical component at a target tissue. The pharmaceutical composition is particularly suitable for administration to or into an ocular environment to treat or control an ocular disease, disorder, or condition.

US Patent:

20090239836, Sep 24, 2009

Filed:

Mar 5, 2009

Appl. No.:

12/398202

Inventors:

Mary Lee Ciolkowski - Fairport NY, US
Yan Huang - Webster NY, US
Martin J. Coffey - Pittsford NY, US

International Classification:

A61K 31/56
A61K 31/55
A61K 31/498
A61K 31/496
A61K 31/437
A61K 31/4709
A61K 47/10

US Classification:

514179, 51421707, 514249, 51425307, 514300, 514314, 514772

Abstract:

An multifunctional ophthalmic composition includes a nonionic oxygen-containing polymer and a surfactant. The composition can be used to treat or control ophthalmic diseases, conditions, or disorders. The composition can be a drug delivery vehicle for medicaments having low solubility in water.